Elizabeth Trehu - Chief Medical Officer, Jounce Therapeutics, Inc

As of March 31, 2021


Elizabeth Trehu Net Worth

  • Net worth is estimated to be at least $835.58K
  • Owns at least 93,585 units of Jounce Therapeutics, Inc stock
  • Sold an estimated value of $502.41K in the last 3 years at Jounce Therapeutics, Inc

Elizabeth Trehu Trading

  • Largest purchase of shares was 13,500 units , worth over $54.27K on March 31, 2021
  • Largest sale of shares was 13,500 units , worth over $136.21K on March 31, 2021
  • In total has made about 14 transactions over 3 years
  • Usually trades in February, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Elizabeth Trehu Mailing Address

  • Mailing address is C/o Jounce Therapeutics, Inc. 1030 Massachusetts Avenue Cambridge MA 02138 MA

Jounce Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Richard Murray, Ph.D., 2020 $565,100 $310,810 $491,316 $627,312 $8,946 $2,003,484
Richard Murray, Ph.D., 2019 $540,800 $295,500 $275,044 $348,665 $8,796 $1,468,805
Hugh M. Cole 2020 $420,000 $212,520 $196,500 $250,908 $8,808 $1,088,736
Hugh M. Cole 2019 $401,700 $153,700 $97,900 $124,115 $5,709 $783,124
Kim C. Drapkin 2020 $398,400 $175,300 $174,885 $223,308 $8,688 $980,581
Kim C. Drapkin 2019 $381,200 $145,800 $97,900 $124,115 $8,796 $757,811
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1640455/000164045521000078/jnce042621def14a.htm

Jounce Therapeutics, Inc Insider Trading

  • The most recent transaction was 552,520 units sold on May 27, 2021 by Third Rock Ventures Ii Lp, Third Rock Ventures GP Ii Lp, Trv GP Ii Llc, Kevin Starr, Robert Tepper and Mark Levin worth over $4.42M
  • In the last 4 years, insiders at Jounce Therapeutics, Inc sold an estimated value of $26.04M and bought an estimated value of $10.7M
  • The most active traders are Elizabeth Trehu, Chief Medical Officer,  Kimberlee C Drapkin, CFO and Treasurer,  and Ca Richard Murray, CEO and President
  • Insider trading is most common in June, with the busiest year in 2021

Jounce Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1